Zobrazeno 1 - 10
of 71
pro vyhledávání: '"Alfred Schauer"'
Autor:
Alfred Schauer, D Marx, Martin C. Jäckel, Mansur A. Dorudian, Wolfgang Steiner, Ulrich Brinck
Publikováno v:
Cancer. 85:591-599
BACKGROUND bcl-2 and bax genes are known to be involved in the control of apoptotic cell death, an important mechanism of growth regulation that influences the biologic behavior of tumors. The aim of the current study was to investigate the relations
Publikováno v:
European Journal of Cancer. 34:845-850
Drug resistance is one of the most important clinical problems in the treatment of ovarian cancer. This study was designed to determine whether expression of p53 could be used as a marker for predicting the response to chemotherapy of ovarian cancer.
Autor:
Willi Sauerbrei, H. F. Rauschecker, Wolfgang Gatzemeier, Alfred Schauer, C. Schmoor, Martin Schumacher, Rolf Sauer
Publikováno v:
European Journal of Cancer. 34:315-323
In this report, the results of the first controlled clinical trial on breast cancer in Germany, begun in 1983, are presented after a median follow-up of 8 years. Four-year results have been previously published. In pT1 N0 M0 breast cancer, mastectomy
Autor:
Alfred Schauer, Manfred Fischer, Robert M. Dunn, Dieter L. Munz, Heinz Becker, Michael Hüfner, Wolfgang Becker, Stefan Gratz, Thomas M. Behr, Peter M. Markus
Publikováno v:
Cancer. 80:2436-2457
BACKGROUND Surgery is currently the only potentially curative approach in the treatment of medullary thyroid carcinoma (MTC). In many instances however, postsurgically elevated or rising plasma calcitonin and/or carcinoembryonic antigen (CEA) levels
Publikováno v:
European Radiology. 7:1002-1005
The objective of this study was to evaluate the prognostic value of contrast-enhanced MR mammography in patients with breast cancer. A total of 190 patients with breast cancer (37 noninvasive carcinomas, 153 invasive carcinomas) underwent dynamic con
Autor:
Alfred Schauer, Claudia Schmoor, Martin Schumacher, Willi Sauerbrei, R. Sauer, M. Olschewski, Seegenschmiedt Mh, H. Rauschecker
Publikováno v:
Breast Cancer Research and Treatment. 34:1-13
Background: In the early 1980s breast preservation was a rarely applied therapeutic modality in the primary treatment of breast cancer in the Federal Republic of Germany. Reports coming from retrospective studies as well as preliminary results from r
Autor:
Alfred Schauer, Werner Rath, D Marx, Wolfgang Wuttke, A. Fattahi, Harald Meden, M. Kron, Walther Kuhn
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 120:378-381
Amplification of the proto-oncogene c-erbB-2 (HER-2/neu) has been shown to be a prognostic marker in ovarian cancer. In order to obtain further information on the biological role of the c-erbB-2 gene product p185 it is necessary to quantify expressio
Autor:
Martin Schumacher, Wolfgang Gatzemeier, Willi Sauerbrei, L. Ummenhofer, C. Schmoor, Alfred Schauer, H. Rauschecker
Publikováno v:
Breast Cancer Research and Treatment. 25:235-245
The prognostic effect of histological tumor grade was evaluated in 1036 patients with early breast cancer (pT1 pN0 M0) entered into a trial comparing mastectomy and breast preserving treatment. All analyses were adjusted for the factors treatment, pa
Autor:
Heinrich Kreuzer, R. Lamberts, Reinhold Schuster, Werner Creutzfeldt, Rainer E. de Vivie, Alfred Schauer, Ulrich Tebbe, Werner Peitsch, Rolf Nitsche
Publikováno v:
Digestion. 53:200-209
An 18-year-old female patient was admitted with ascites, right upper abdominal tenderness and peripheral edema. Angiography showed complete occlusion of the vena cava inferior up to the level of the right atrium. By open heart surgery, masses of thro
Autor:
Rolf Sauer, Alfred Schauer, H. Rauschecker, Seegenschmiedt Mh, Martin Schumacher, Wolfgang Gatzemeier, D. Marx, J. Dunst, C. Schmoor
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 23:907-914
In 1983, The German Breast Cancer Study Group, sponsored by the Federal Ministry of Research and Technology, started a prospective multicenter trial on the treatment of early breast cancer pT1 pN0 M0. Treatment consisted of initial tumorectomy with m